Oxandrolone 25mg (Anavar) | NexorinPharma
Oxandrolone 25mg is an oral anabolic steroid containing 25mg of Oxandrolone per tablet. At NexorinPharma, we carry Oxandrolone 25mg as part of our oral anabolic steroid inventory for customers in markets where Oxandrolone is legally available.
Oxandrolone is the active compound in this preparation, widely known under the brand name Anavar. It carries active FDA approval for specific medical indications and has one of the most extensively documented clinical research bases of any anabolic steroid discussed in performance communities.
The 25mg per tablet concentration represents a higher per-tablet dose than the standard 10mg maximum pharmaceutical grade Oxandrolone tablet format. This distinction is important context for anyone researching this specific product. This page covers what Oxandrolone is, how it works, and what health and legal considerations apply. It does not constitute medical advice, recommend steroid use, or provide dosage, cycle, or stacking guidance of any kind.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Oxandrolone 25mg |
| Active Compound | Oxandrolone |
| Also Known As | Anavar, Var, Oxandrin |
| Drug Class | Anabolic-androgenic steroid, 17-alpha alkylated oral steroid, DHT derivative |
| Concentration | 25mg per tablet |
| Presentation | Oral tablet |
| Form | Tablet |
| Half-Life | Approximately 9 to 10 hours |
| Route of Administration | Oral |
| Anabolic Rating | 322 to 630 relative to testosterone baseline of 100 |
| Androgenic Rating | 24 relative to testosterone baseline of 100 |
| Aromatization | None |
| 17-Alpha Alkylated | Yes |
| Liver Toxicity | Mild to moderate |
| FDA Approval | Yes. Active FDA approval for specific indications under the Oxandrin brand name. |
| Legal Status | Schedule III controlled substance in the United States. Prescription required. Legal status varies by country. |
| Availability | nexorinpharma.com |
About the 25mg Concentration
The 25mg per tablet concentration represents two and a half times the maximum standard pharmaceutical grade Oxandrolone tablet format of 10mg. Understanding this distinction is important context for anyone researching this specific product.
Comparison With Standard Clinical Formats
The FDA-approved Oxandrin product is available in 2.5mg and 10mg tablet formats. The 25mg concentration consequently exceeds the maximum standard pharmaceutical tablet format for Oxandrolone by two and a half times. The clinical research base for Oxandrolone was established primarily at doses consistent with the 2.5mg and 10mg pharmaceutical formats. As a result, the 25mg concentration carries side effect considerations that exceed those reflected in the standard clinical research base.
Comparison With 10mg Format
The 10mg format aligns with the maximum standard pharmaceutical clinical tablet format for Oxandrolone. The 25mg format delivers two and a half times the active compound per tablet compared to the 10mg format. Consequently, dose-dependent side effect considerations including liver toxicity and cardiovascular impact are more pronounced per tablet at the 25mg concentration than at the 10mg format.
Comparison With Higher Non-Prescription Formats
Higher concentration Oxandrolone tablet formats of 40mg and 50mg are available in non-prescription markets. The 25mg format consequently sits between the standard 10mg clinical format and these higher concentration non-prescription formats. As a result, it provides a middle-ground concentration that exceeds standard clinical dosing while remaining below the highest available non-prescription formats.
Non-Prescription Market Context
Oxandrolone 25mg is produced for markets where Oxandrolone is legally available outside of prescription channels. It does not carry the manufacturing oversight, regulatory scrutiny, or clinical documentation of pharmaceutical grade prescription products. Quality, purity, and concentration accuracy are consequently less verifiable than with regulated products.
What Is Oxandrolone
Oxandrolone is a synthetic anabolic-androgenic steroid derived from Dihydrotestosterone. Searle Laboratories developed it in 1962 and introduced it to the US market under the brand name Anavar in 1964. From the beginning, it was developed with a specific goal of producing a compound with strong anabolic activity and minimal androgenic effects relative to its anabolic potency.
Structurally, Oxandrolone is a modified form of DHT. Two key structural modifications define it. First, a methyl group at the 17-alpha position allows it to survive first-pass liver metabolism when taken orally. Second, an oxygen atom replaces the carbon-2 atom in the A-ring of the steroid structure. This second modification is directly responsible for Oxandrolone’s unusually high anabolic-to-androgenic ratio and its complete resistance to aromatization. Together, these modifications produce an oral anabolic steroid with an anabolic rating of 322 to 630 and an androgenic rating of only 24 relative to a testosterone baseline of 100.
How Oxandrolone Works
Oxandrolone is active when taken orally. The 17-alpha alkylation allows it to pass through the liver without complete breakdown, reaching systemic circulation in active form.
Androgen Receptor Binding
Oxandrolone binds to androgen receptors throughout the body. Its androgenic activity is significantly lower than testosterone despite its high anabolic rating. As a result, androgen receptor activation in muscle tissue drives its anabolic effects while producing comparatively minimal androgenic activity in androgen-sensitive tissues like skin and hair follicles.
Nitrogen Retention
Oxandrolone produces positive nitrogen retention in muscle tissue. The body retains more nitrogen than it excretes. Consequently, this supports an anabolic environment that favors muscle repair and preservation. This mechanism is particularly relevant in clinical contexts where muscle wasting prevention is a primary treatment goal.
Protein Synthesis
Oxandrolone accelerates protein synthesis in skeletal muscle tissue. Faster protein synthesis supports muscle repair and growth following training or tissue stress. This mechanism is directly tied to its anabolic receptor activity and contributes to its documented clinical efficacy across multiple indications.
No Aromatization
Oxandrolone does not convert to estrogen through the aromatase enzyme pathway. As a DHT derivative, it is not a substrate for aromatase. Consequently, estrogen-related side effects including water retention and gynecomastia are not part of its direct pharmacological profile. This characteristic distinguishes Oxandrolone from testosterone and many other anabolic steroids where estrogenic conversion is a primary side effect consideration.
IGF-1 Stimulation
Oxandrolone increases Insulin-like Growth Factor 1 production. IGF-1 plays a direct role in muscle repair, recovery, and anabolic activity throughout the body. This mechanism consequently contributes to the muscle preservation and recovery effects documented across Oxandrolone’s clinical research base.
Creatine Phosphate Synthesis
Oxandrolone enhances creatine phosphate synthesis in muscle tissue. Creatine phosphate is a primary energy substrate for high-intensity muscular activity. As a result, enhanced creatine phosphate availability supports strength and power output during physical activity and is one of the documented pharmacological mechanisms of Oxandrolone.
Clinical Background
Oxandrolone carries a more extensive clinical history than virtually any other anabolic steroid discussed in performance communities.
FDA Approval and Current Indications
The FDA approved Oxandrolone under the brand name Oxandrin. Unlike most anabolic steroids, Oxandrolone retains active FDA approval today. Its current approved indications include weight regain following involuntary weight loss associated with surgery, chronic infection, trauma, or prolonged corticosteroid use. It is also approved for the treatment of bone pain associated with osteoporosis.
HIV and AIDS-Related Muscle Wasting
Oxandrolone has extensive clinical research documentation in the treatment of HIV and AIDS-related muscle wasting. Multiple controlled clinical trials document its efficacy in preserving and restoring lean body mass in HIV-positive patients experiencing involuntary weight loss. This clinical application consequently represents one of the most well-documented uses of any anabolic steroid in modern medical research.
Burns and Wound Healing
Clinical research documents Oxandrolone’s efficacy in accelerating recovery and preserving lean body mass in severe burn patients. Studies in both pediatric and adult burn patients demonstrate meaningful improvements in recovery outcomes with Oxandrolone use under medical supervision. As a result, burn treatment represents one of its most consistently supported clinical applications in the literature.
Turner Syndrome
Researchers have studied and used Oxandrolone clinically in girls with Turner syndrome to promote linear growth. This pediatric application reflects its documented low androgenic activity and relative safety profile compared to other anabolic steroids at appropriate clinical doses.
Oxandrolone 25mg Versus Other Oral Anabolic Steroids
Versus Oxandrolone 10mg
Both preparations contain the same active compound with identical pharmacological profiles. The 25mg format delivers two and a half times the active compound per tablet compared to the 10mg format. As a result, dose-dependent side effect considerations are more pronounced per tablet at the 25mg concentration. The 10mg format aligns with the maximum standard pharmaceutical clinical tablet format while the 25mg format exceeds standard clinical dosing.
Versus Methandrostenolone (Dianabol)
Methandrostenolone aromatizes significantly to estrogen and carries significant liver toxicity. Oxandrolone 25mg, on the other hand, produces no estrogenic conversion and carries milder liver toxicity despite its higher concentration. As a result, Oxandrolone 25mg represents a considerably milder pharmacological profile than Methandrostenolone across virtually all side effect parameters even at the higher 25mg concentration.
Versus Oxymetholone (Anadrol)
Oxymetholone carries significant liver toxicity and pronounced estrogenic effects. Compared to Oxymetholone, Oxandrolone 25mg produces dramatically lower liver stress, no estrogenic conversion, and a significantly more favorable overall side effect profile. These two compounds consequently occupy fundamentally different positions on the oral anabolic steroid potency and risk spectrum.
Versus Stanozolol (Winstrol)
Stanozolol is a non-aromatizing oral anabolic steroid with more significant liver toxicity and more pronounced adverse lipid effects than Oxandrolone. Stanozolol’s androgenic activity also exceeds Oxandrolone’s very low androgenic rating of 24. Oxandrolone 25mg consequently represents a milder profile than Stanozolol across liver and androgenic side effect parameters despite its higher concentration.
Versus Methenolone Acetate (Oral Primobolan)
Methenolone Acetate carries lower liver toxicity than Oxandrolone due to its non-17-alpha alkylated structure. However, Oxandrolone carries significantly higher anabolic activity than Methenolone Acetate at any concentration. As a result, these two non-aromatizing oral compounds carry distinct trade-offs between anabolic potency and hepatotoxicity risk.
Side Effects and Health Risks
Oxandrolone 25mg carries a side effect profile based on the well-documented Oxandrolone pharmacological profile. The higher 25mg concentration compared to the standard 10mg pharmaceutical format makes dose-dependent side effect considerations more pronounced.
Liver Toxicity
Oxandrolone is a 17-alpha alkylated oral steroid. The alkylation places stress on liver tissue. Oxandrolone’s liver toxicity is consistently documented as milder than other 17-alpha alkylated oral anabolic steroids. However, at the 25mg concentration, liver stress considerations are more relevant than at the standard 10mg pharmaceutical format. Liver monitoring through regular blood work is therefore essential for anyone using this compound at any concentration.
Cardiovascular Effects
Oxandrolone produces adverse lipid profile changes. HDL cholesterol decreases while LDL cholesterol increases. At the 25mg concentration, these cardiovascular considerations are more pronounced than at the 10mg format. Regular lipid monitoring is therefore important for anyone using this compound.
Androgenic Effects
Despite its very low androgenic rating of 24, Oxandrolone still produces androgenic side effects in susceptible individuals. These include accelerated hair loss in genetically predisposed individuals and acne. In women, virilization risks are serious considerations. At the 25mg concentration, these androgenic considerations are consequently more pronounced than at the 10mg format.
Hormonal Suppression
Oxandrolone suppresses the hypothalamic-pituitary-gonadal axis and the body’s natural testosterone production. The degree of suppression is generally considered less pronounced than with more potent anabolic steroids. However, post-use hormonal disruption remains a relevant consideration and is more pronounced at the 25mg concentration than at standard clinical doses.
Psychological Effects
Anabolic steroid use carries documented associations with mood changes and irritability. These considerations apply to Oxandrolone use at any concentration and are consequently more pronounced at the 25mg format than at the lower 10mg concentration.
Legal and Regulatory Status
Oxandrolone retains active FDA approval under the brand name Oxandrin for specific clinical indications. Outside of those indications, it carries Schedule III controlled substance status in the United States. Possession without a valid prescription is consequently a federal offense.
In the United Kingdom, Oxandrolone falls under Class C of the Misuse of Drugs Act. Supply is illegal.
The World Anti-Doping Agency bans Oxandrolone alongside all major athletic governing bodies. It consequently appears on prohibited substance lists across Olympic sports, professional athletics, and competitive bodybuilding organizations that conduct testing.
You are responsible for confirming the legal status of Oxandrolone in your specific jurisdiction before purchasing from NexorinPharma.
Frequently Asked Questions
Is Oxandrolone 25mg Available at NexorinPharma
Yes. NexorinPharma carries Oxandrolone 25mg for customers in markets where Oxandrolone is legally available. Visit nexorinpharma.com to check current availability and pricing.
What Is the Half-Life of Oxandrolone
Oxandrolone produces a half-life of approximately 9 to 10 hours. As a result, active plasma concentrations are sustained longer than shorter half-life oral anabolic steroids while still requiring regular oral administration to maintain stable levels.
How Does the 25mg Concentration Compare to the 10mg Format
Both preparations contain the same active Oxandrolone compound with identical pharmacological profiles. The 25mg format delivers two and a half times the active compound per tablet compared to the 10mg format. The 10mg format aligns with the maximum standard pharmaceutical clinical tablet format while the 25mg format consequently exceeds standard clinical dosing by two and a half times.
Does Oxandrolone Aromatize
No. Oxandrolone does not convert to estrogen through the aromatase enzyme pathway. As a DHT derivative, it is not a substrate for aromatase. Consequently, estrogen-related side effects are not part of its direct pharmacological profile.
What Are the Most Serious Health Risks
Cardiovascular effects from lipid dysregulation are among the most clinically significant concerns with Oxandrolone. In addition, hormonal suppression, androgenic effects, and liver enzyme elevation complete the primary risk profile. These considerations are more pronounced at the 25mg concentration than at the standard 10mg pharmaceutical format. Medical supervision and regular blood work monitoring are therefore essential for anyone using this compound.
Is Oxandrolone 25mg Legal to Purchase
Oxandrolone carries Schedule III controlled substance status in the United States and requires a valid prescription. Legal status varies by jurisdiction. You are consequently responsible for confirming the legal status in your jurisdiction before purchasing from NexorinPharma.
What to Consider Before Purchasing Oxandrolone 25mg
Oxandrolone has one of the most extensive clinical research bases of any anabolic steroid discussed in performance communities. Its active FDA approval, documented clinical applications, and decades of controlled clinical trial data provide a substantially stronger research foundation than most anabolic steroids carry. That research base applies to the pharmacological and risk profile of the active compound regardless of the specific concentration format.
The 25mg concentration exceeds the maximum standard pharmaceutical clinical tablet format of 10mg by two and a half times. As a result, the dose-dependent side effect considerations associated with Oxandrolone are more relevant at the 25mg concentration than the clinical research base at standard pharmaceutical doses fully reflects.
Oxandrolone carries documented cardiovascular, liver, hormonal, androgenic, and psychological health risks. These risks require medical supervision to manage responsibly. Regular blood work monitoring including liver enzymes, lipid panels, and hormone levels is therefore essential for anyone using this compound.
For customers in markets where Oxandrolone is legally available, visit nexorinpharma.com to check current Oxandrolone 25mg availability, pricing, and stock levels.




Reviews
There are no reviews yet.